References
- WHO. Palliative care. 2021. https://www.who.int/health-topics/palliative-care.
- Lustbader D, Mudra M, Romano C, et al. The impact of a Home-Based palliative care program in an accountable care organization. J Palliat Med. 2017;20(1):23–28.
- Isenberg SR, Lu C, McQuade J, et al. Impact of a new palliative care program on health system finances: an analysis of the palliative care program inpatient unit and consultations at johns hopkins medical institutions. J Oncol Pract. 2017;13(5):e421–e430.
- Morrison RS, Dietrich J, Ladwig S, et al. Palliative care consultation teams cut hospital costs for medicaid beneficiaries. Health Aff (Millwood)). 2011;30(3):454–463.
- WHO. WHO Global Atlas of Palliative Care. 2021. https://www.who.int/nmh/Global_Atlas_of_Palliative_Care.pdf
- STM 2010. Syövän hoidon kehittäminen vuosina 2010-2020. Työryhmän raportti. Sosiaali-ja terveysministeriön selvityksiä 2010:6.STM. 2021. https://julkaisut.valtioneuvosto.fi/bitstream/handle/10024/72793/selv_2010_6_syovan_hoito_verkko.pdf?sequence=1&isAllowed=y
- Kaasa S, Loge JH, Aapro M, et al. Integration of oncology and palliative care: a lancet oncology commission. The Lancet.Oncology. 2018;19(11):e588–e653.
- STM 2019. Alueellinen kartoitus ja ehdotuksia laadun ja saatavuuden parantamiseksi Palliatiivisen hoidon ja saattohoidon tila Suomessa.STM; 2021. https://julkaisut.valtioneuvosto.fi/bitstream/handle/10024/161946/STM_2019_68_Rap.pdf?sequence=1&isAllowed=y
- Recommendation Rec 2003. 24 of the Committee of Ministers to member states on the organisation of palliative care. Adopted by the Committee of Ministers on 12 November 2003 at the 860th meeting of the Ministers’ Deputies.Council of Europe; 2021. https://www.coe.int/t/dg3/health/Source/Rec(2003)24_en.pdf
- Hui D, Meng YC, Bruera S, et al. Referral criteria for outpatient palliative cancer care: a systematic review. Oncologist. 2016;21(7):895–901.
- Engeser P, Leutgeb R, Glassman J, et al. Identifying palliative patients in general practice: Focusing on the place of death and the vital role of specialized home palliative care: an observational study. J Palliat Med. 2020;23(12):1626–1630.
- Ho TH, Barbera L, Saskin R, et al. Trends in the aggressiveness of end-of-Life cancer care in the universal health care system of Ontario, Canada. J Clin Oncol. 2011;29(12):1587–1591.
- Earle CC, Neville BA, Landrum MB, et al. Trends in the aggressiveness of cancer care near the End of Life. J Clin Oncol. 2004;22(2):315–321.
- Adam H, Hug S, Bosshard G. Chemotherapy near the End of Life: A Retrospective Single-Centre Analysis of Patients' Charts. BMC Palliat Care. 2014;13:26.
- Prigerson HG, Bao Y, Shah MA, et al. Chemotherapy use, performance status, and quality of life at the end of Life. JAMA Oncol. 2015;1(6):778–784.
- Nappa U, Lindqvist O, Rasmussen BH, et al. Palliative chemotherapy during the last month of life. Ann Oncol. 2011;22(11):2375–2380.
- Mack JW, Cronin A, Taback N, et al. End-of-Life care discussions among patients with advanced cancer: a cohort study. Ann Intern Med. 2012;156(3):204–210.
- EAPC Blog. 2021. Together towards better palliative care education for nurses and physicians – the EduPal (Finland) project. https://eapcnet.wordpress.com/2021/03/22/together-towards-better-palliative-care-education-for-nurses-and-physicians-the-edupal-finland-project/
- McDonald JC, Du Manoir JM, Kevork N, et al. Advance directives in patients with advanced cancer receiving active treatment: Attitudes, prevalence, and barriers. Support Care Cancer. 2017;25(2):523–531.
- Liang YH, Wei CH, Hsu WH, et al. Do-Not-Resuscitate consent signed by patients indicates a more favorable quality of end-of-Life care for patients with advanced cancer. Support Care Cancer. 2017;25(2):533–539.
- Garrido MM, Balboni TA, Maciejewski PK, et al. Quality of life and cost of care at the end of life: the role of advance directives. J Pain Symptom Manage. 2015;49(5):828–835.
- Pfirstinger J, Kattner D, Edinger M, et al. The impact of a tumor diagnosis on patients' attitudes toward advance directives. Oncology. 2014;87(4):246–256.
- Hirvonen OM, Alalahti JE, Syrjanen KJ, et al. End-of-Life decisions guiding the palliative care of cancer patients visiting emergency department in South Western Finland: a retrospective cohort study. BMC Palliat Care. 2018;17(1):128.
- Hoitoonpääsyn seuranta syövän hoidossa. THL 2021. https://www.julkari.fi/bitstream/handle/10024/131630/URN_ISBN_978-952-302-782-4.pdf?sequence=1&isAllowed=y
- Davies JM, Gao W, Sleeman KE, et al. Using routine data to improve palliative and end of life care. BMJ Support Palliat Care. 2016;6(3):257–262.
- Stubbs JM, Assareh H, Achat HM, et al. Verification of administrative data to measure palliative care at terminal hospital stays.Health information management. Him J. 2020;1833358320968572.
- Greer JA, Pirl WF, Jackson VA, et al. Effect of early palliative care on chemotherapy use and end-of-Life care in patients with metastatic Non-Small-Cell lung cancer. J Clin Oncol. 2012;30(4):394–400.
- Urvay S, Civelek B, Ozaslan E, et al. Chemotherapy at the end of life. J Palliat Care. 2021;36(2):73–77.
- Numico G, Trogu A, Cristofano A, et al. Active treatment given in the last weeks of life: Poor quality cancer care or justifiable behavior? Support Care Cancer. 2014;22(10):2813–2819.
- Lee HS, Chun KH, Moon D, et al. Trends in receiving chemotherapy for advanced cancer patients at the end of life. BMC Palliat Care. 2015;14:4.
- Pacetti P, Paganini G, Orlandi M, et al. Chemotherapy in the last 30 days of life of advanced cancer patients. Support Care Cancer. 2015;23(11):3277–3280.
- Anshushaug M, Gynnild MA, Kaasa S, et al. Characterization of patients receiving palliative chemo- and radiotherapy during end of life at a regional cancer center in Norway. Acta Oncologica. 2015;54(3):395–402.
- Hirvonen OM, Leskela RL, Gronholm L, et al. Assessing the utilization of the decision to implement a palliative goal for the treatment of cancer patients during the last year of life at helsinki university hospital: a historic cohort study. Acta Oncol. 2019;58(12):1699–1705.
- Rautakorpi LK, Seyednasrollah F, Makela JM, et al. End-of-Life chemotherapy use at a finnish university hospital: a retrospective cohort study. Acta Oncol. 2017;56(10):1272–1276.
- Rautakorpi LK, Makela JM, Seyednasrollah F, et al. Assessing the utilization of radiotherapy near end of life at a finnish university hospital: a retrospective cohort study. Acta Oncol. 2017;56(10):1265–1271.
- Dennis K, Wong K, Zhang L, et al. Palliative radiotherapy for bone metastases in the last 3 months of life: Worthwhile or futile?Clinical oncology (royal college of radiologists. Clin Oncol. 2011;23(10):709–715.
- McDonald R, Ding K, Brundage M, et al. Effect of radiotherapy on painful bone metastases: a secondary analysis of the NCIC clinical trials group symptom control trial SC.23. JAMA Oncol. 2017;3(7):953–959.
- Jones JA, Lutz ST, Chow E, et al. Palliative radiotherapy at the end of life: a critical review. CA Cancer J Clin. 2014;64(5):296–310.